Cover Image
Market Research Report - 246389

Atopic Dermatitis Global Clinical Trials Review, H2, 2015

Published by GlobalData
Published Content info 332 Pages
Price
Back to Top
Atopic Dermatitis Global Clinical Trials Review, H2, 2015
Published: October 21, 2015 Content info: 332 Pages
Description

GlobalData's clinical trial report, "Atopic Dermatitis Global Clinical Trials Review, H2, 2015" provides an overview of Atopic Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic Dermatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Atopic Dermatitis to Dermatology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Atopic Dermatitis to Dermatology Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Atopic Dermatitis Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Latest Clinical Trials News on Atopic Dermatitis 29
  • Oct 09, 2015: Celgene Announces New Data for OTEZLA Will Be Presented at European Academy of Dermatology and Venereology Congress 29
  • Sep 29, 2015: Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences 30
  • Sep 21, 2015: Provectus Biopharmaceuticals Completes Patient Accrual for PH-10 Phase 2 Clinical Study of Cellular and Immunologic Changes in the Skin 30
  • Sep 03, 2015: Glenmark's Novel Monoclonal Antibody GBR 830 to Enter Phase 2 Clinical Studies in Atopic Dermatitis and Celiac Disease in US and Europe 31
  • Clinical Trial Profile Snapshots 32

Appendix 329

  • Abbreviations 329
  • Definitions 329
  • Research Methodology 330
  • Secondary Research 330
  • About GlobalData 331
  • Contact Us 331
  • Disclaimer 331
  • Source 332

List of Tables

List of Tables

  • Atopic Dermatitis Therapeutics, Global, Clinical Trials by Region, 2015* 6
  • Atopic Dermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
  • Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
  • Atopic Dermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 9
  • Atopic Dermatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
  • Atopic Dermatitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
  • Atopic Dermatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 12
  • Atopic Dermatitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 13
  • Proportion of Atopic Dermatitis to Dermatology Clinical Trials, G7 Countries (%), 2015* 14
  • Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
  • Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
  • Proportion of Atopic Dermatitis to Dermatology Clinical Trials, E7 Countries (%), 2015* 17
  • Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
  • Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
  • Atopic Dermatitis Therapeutics, Global, Clinical Trials by Phase, 2015* 20
  • Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
  • Atopic Dermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
  • Atopic Dermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
  • Atopic Dermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
  • Atopic Dermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
  • Atopic Dermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
  • Atopic Dermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
  • Atopic Dermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28

List of Figures

List of Figures

  • Atopic Dermatitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
  • Atopic Dermatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
  • Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
  • Atopic Dermatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 9
  • Atopic Dermatitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
  • Atopic Dermatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
  • Atopic Dermatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 12
  • Atopic Dermatitis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 13
  • Proportion of Atopic Dermatitis to Dermatology Clinical Trials, G7 Countries (%), 2015* 14
  • Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
  • Atopic Dermatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
  • Proportion of Atopic Dermatitis to Dermatology Clinical Trials, E7 Countries (%), 2015* 17
  • Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18
  • Atopic Dermatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
  • Atopic Dermatitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
  • Atopic Dermatitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
  • Atopic Dermatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
  • Atopic Dermatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
  • Atopic Dermatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
  • Atopic Dermatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
  • Atopic Dermatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
  • Atopic Dermatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
  • Atopic Dermatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
  • GlobalData Methodology 330
Back to Top